Back

Intrahippocampal delivery of hyperphosphorylated human tau oligomers induces neurodegeneration in non-transgenic wildtype mice

Chen, H.-R.; Hagar, H. T.; Kuo, M.-H.; KUAN, C.-Y.

2025-03-13 neuroscience
10.1101/2025.03.10.642468 bioRxiv
Show abstract

Hyperphosphorylated tau (p-tau) forms neurofibrillary tangles, a key biomarker for Alzheimers disease and additional neurodegenerative tauopathies. However, neurofibrillary tangles are not sufficient to cause neuronal dysfunction or death. Intrahippocampal injection of tau isolated from AD patients has limited effects on the cognitive functions of non-transgenic mice, despite the recapitulation of pathological tau deposits in the mouse brain. It therefore remains uncertain as to whether all hyperphosphorylated tau is directly responsible for AD neurodegeneration. We examined this issue by injecting recombinant p-tau oligomers to the hippocampus of non-transgenic, wildtype mice and found progressive cognitive deficits that correlate with neuron death spreading from the ipsilateral hippocampus to the cortex. Apomorphine, which retards p-tau aggregation and cytotoxicity in vitro, antagonized p-tau-induced cognitive deficits and neuron death. These results suggest the pathogenic role of p-tau oligomers and a novel AD model facilitating drug development.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.